Ami Bhatt | |
---|---|
Alma mater |
University of California, San Francisco Harvard School of Medicine |
Awards | Chen Award of Excellence,
Human Genome Organization (2018)
Emerging Leader in Health and Medicine, National Academy of Medicine (2020) Sloan Research Fellowship (2020) |
Scientific career | |
Fields | Microbiome, hematologic malignancies, bioinformatics |
Institutions | Stanford University |
Website |
www |
Ami Bhatt is an American physician-scientist who studies the link between blood cancers and the human gut microbiome. [1] She holds associate professorships in Genetics and Medicine ( Hematology) at Stanford University. She is a member of Stanford Bio-X, the Stanford Cancer Institute, Stanford Maternal & Child Health Research Institute (MCHRI), and Stanford ChEM-H. [2] [3] In addition, Bhatt is the co-founder of Global Oncology Inc., a nonprofit focused on providing quality oncologic treatment in resource-constrained settings. [4]
Bhatt completed her PhD in Biochemistry and Molecular Biology in 2005 and earned her MD degree in 2007, both from the University of California, San Francisco. [2] She then underwent her residency and chief residency in Internal Medicine at Brigham and Women's Hospital, a teaching hospital of Harvard Medical School. [1] [2] Bhatt then pursued a Hematology and Oncology fellowship at the Dana-Farber Cancer Institute. After this she was a post-doc at the Broad Institute and MIT. [5] [6]
Bhatt won the 2018 Chen Award of Excellence by the Human Genome Organisation. [7]
The Chan Zuckerberg Initiative awarded a $525,000 research grant to Bhatt, along with colleagues Anne Brunet and K. Christopher Garcia, for their project "Analyzing how inflammation affects the aging brain." [8]
Bhatt was named a 2020 Emerging Leader in Health and Medicine by the National Academy of Medicine. [9] She was also a winner of the 2020 Sloan Research Fellowship, in the category "Computational and Evolutionary Molecular Biology." [10]
Bhatt serves on the editorial board for Blood, Journal of Global Oncology, [11] Seminars in Hematology, and The Oncologist. [2]
In November 2020 Bhatt joined the Scientific Advisory board for January AI, a precision medicine company predicting long-term blood glucose level changes with artificial intelligence. [12]
Ami Bhatt | |
---|---|
Alma mater |
University of California, San Francisco Harvard School of Medicine |
Awards | Chen Award of Excellence,
Human Genome Organization (2018)
Emerging Leader in Health and Medicine, National Academy of Medicine (2020) Sloan Research Fellowship (2020) |
Scientific career | |
Fields | Microbiome, hematologic malignancies, bioinformatics |
Institutions | Stanford University |
Website |
www |
Ami Bhatt is an American physician-scientist who studies the link between blood cancers and the human gut microbiome. [1] She holds associate professorships in Genetics and Medicine ( Hematology) at Stanford University. She is a member of Stanford Bio-X, the Stanford Cancer Institute, Stanford Maternal & Child Health Research Institute (MCHRI), and Stanford ChEM-H. [2] [3] In addition, Bhatt is the co-founder of Global Oncology Inc., a nonprofit focused on providing quality oncologic treatment in resource-constrained settings. [4]
Bhatt completed her PhD in Biochemistry and Molecular Biology in 2005 and earned her MD degree in 2007, both from the University of California, San Francisco. [2] She then underwent her residency and chief residency in Internal Medicine at Brigham and Women's Hospital, a teaching hospital of Harvard Medical School. [1] [2] Bhatt then pursued a Hematology and Oncology fellowship at the Dana-Farber Cancer Institute. After this she was a post-doc at the Broad Institute and MIT. [5] [6]
Bhatt won the 2018 Chen Award of Excellence by the Human Genome Organisation. [7]
The Chan Zuckerberg Initiative awarded a $525,000 research grant to Bhatt, along with colleagues Anne Brunet and K. Christopher Garcia, for their project "Analyzing how inflammation affects the aging brain." [8]
Bhatt was named a 2020 Emerging Leader in Health and Medicine by the National Academy of Medicine. [9] She was also a winner of the 2020 Sloan Research Fellowship, in the category "Computational and Evolutionary Molecular Biology." [10]
Bhatt serves on the editorial board for Blood, Journal of Global Oncology, [11] Seminars in Hematology, and The Oncologist. [2]
In November 2020 Bhatt joined the Scientific Advisory board for January AI, a precision medicine company predicting long-term blood glucose level changes with artificial intelligence. [12]